BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2010
View Archived Issues
New selective ligands of GABA(A) alpha5 receptor claimed
Read More
Enrollment complete in phase III trial of subcutaneous Herceptin in HER2+ breast cancer
Read More
Topaz Pharma completes phase III trials of topical ivermectin for head lice
Read More
Development of cancer stem cell-targeting agents SL-401 and SL-501 continues
Read More
Phase I data presented on volociximab/ranibizumab combination in wet AMD
Read More
First-in-human trial supports benefits of BKT-140 in autologous transplantation for multiple myeloma
Read More
CUDC-101 shows good tolerability in first-in-human trial in advanced solid tumors
Read More
Preclinical data presented on antitumor candidates 4SC-202 and 4SC-207
Read More
Radient Pharma and Jaiva Technologies form NuVax Therapeutics
Read More
Geron obtains license to Angiochem's peptide technology and ANG-1005
Read More
European approval of Brilique for prevention of atherothrombotic events
Read More
Alexza provides regulatory update for Staccato Loxapine
Read More
BELLUS Health presents new amino acid derivatives as analgesics
Read More
NRC claims new neuraminidase inhibitors
Read More
Cephalon and Mesoblast join to develop mesenchymal precursor stem cell therapies
Read More
New TRPV1 channel ligands disclosed
Read More
Ascenta and LLS collaborate to develop AT-406
Read More
Dynavax reports data from phase Ia trial of universal flu vaccine component
Read More
FDA advisory committee makes recommendation on vandetanib NDA
Read More
Alkermes presents phase II data on ALKS-33 in alcohol dependence
Read More
Galapagos completes first-in-human study of GLPG-0492 in cachexia
Read More
FDA committee recommends approval of obesity treatment Contrave
Read More
Baylor Research Institute and Roche partner for immunology research
Read More
Polyphor divulges new chemokine CXCR4 receptor antagonists
Read More
FDA orphan drug status for QLT-091001 in retinitis pigmentosa and LCA
Read More
